Mease PJ, Merrill JT, Lahita R, et al. GL701 (prasterone, dehydroepiandrosterone) improves or stabilizes disease activity in systemic lupus erythematosus. Presented at: The Endocrine Society’s 82nd Annual Meeting; Toronto, Canada; June 21-24, 2000.
van Vollenhoven RF, Morabito LM, Engleman EG, et al. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months.
J Rheumatol. 1998;25:285-289.
van Vollenhoven RF, Park JL, Genovese MC, et al. A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.
Lupus.
1999;8:181-187.
Robinzon B, Cutulo M. Should dehydroepiandrosterone replacement therapy be provided with glucocorticoids?
Rheumatology (Oxford).
1999;38:488-495.
van Vollenhoven RF, Park JL, Genovese MC, et al. A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.
Lupus.
1999;8:181-187.
Hall AV, Parbtani A, Clark WF, et al. Abrogation of MRL/lpr lupus nephritis by dietary flaxseed.
Am J Kidney Dis. 1993;22:326-332.
Clark WF, Parbtani A, Huff MW, et al. Flaxseed: a potential treatment for lupus nephritis.
Kidney Int. 1995;48:475-480.
Walton AJE, Snaith MJ, Locniskar M, et al. Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus.
Ann Rheum Dis. 1991;50:463-466.
Clark WF, Parbtani A, Naylor CD, et al. Fish oil in lupus nephritis: clinical findings and methodological implications.
Kidney Int. 1993;44:75-86.
Clark WF, Parbtani A. Omega-3 fatty acid supplementation in clinical and experimental lupus nephritis.
Am J Kidney Dis. 1994;23:644-647.
Roberts JL, Hayashi JA. Exacerbation of SLE associated with alfalfa ingestion [letter].
N Engl J Med. 1983;308:1361.
Malinow MR, Bardana EJ, Pirofsky B, et al. Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid.
Science. 1982;216:415-417.
Chang DM, Lan JL, Lin HY, et al. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: A multicenter randomized, double-blind, placebo-controlled trial.
Arthritis Rheum.
2002;46:2924-2927.
Duffy EM, Meenagh GK, McMillan SA, et al. The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus.
J Rheumatol. 2004;31:1551.
Nordmark G, Bengtsson C, Larsson A, et al. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus.
Autoimmunity.
2005;38:531-40.
Crosbie D, Black C, McIntyre L, et al. Dehydroepiandrosterone for systemic lupus erythematosus.
Cochrane Database Syst Rev.
2007;CD005114.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.